Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapy is a research paper published in Antimicrobial Agents and Chemotherapy (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: K23AI125122 R21AI150347 to H.E.R.
Harvard University Center for AIDS Research
Grant: P30 AI060354 to H.E.R.
U.S. President's Emergency Plan for AIDS Relief
Grant: U51HA02522 U2GGH002098
HHS | National Institutes of Health
Grant: R01 HD058972-01
National Institutes of Health
Grant: 5R21AI150347-02
Rifabutin pharmacokinetics and safety among HIV/TB coinfected infants receiving lopinavir
National Institutes of Health
Grant: 5P30AI060354-18
Harvard University Center for AIDS Research
National Institutes of Health
Grant: 5R01HD058972-03
Impact of malnutrition on TB-IRIS and pharmacokinetics of TB and ARV co-treatment
National Institutes of Health
Grant: 5K23AI125122-02
Pharmacokinetic and Programmatic Evaluations to Optimize HIV/TB Co-Treatment Regimens in Children
Fields of Study
Keywords